CorMedix (CRMD) Return on Sales [ROS] (2013 - 2026)
CorMedix (CRMD) posted Return on Sales [ROS] of 42.10% for Q2 2026, down 7.09 percentage points from 49.18% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Return on Sales [ROS] (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at CorMedix was 46.17%, up 5.57 percentage points year-over-year; for FY2025, it was 48.17%, up 99.59 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +11426.61 percentage points (FY2020 to FY2025).
- In prior years, CorMedix's Return on Sales [ROS] was -51.43% in FY2024, -46819.91% in FY2022 (-31402.40 pp) and -15417.51% in FY2021 (-4039.08 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q4 2024.
- On a year-over-year basis, Return on Sales [ROS] increased in three of the last four quarters, with an average year-over-year change of +505.66 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2022, with a gain of 33040.22 percentage points; the weakest was Q1 2022, with a drop of 83925.29 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | CorMedix | 417.07 Mn | -222.82 Mn | 77.13 Mn | 42.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.10% |
| Mar 31, 2026 | 49.96% |
| Dec 31, 2025 | 45.97% |
| Sep 30, 2025 | 49.24% |
| Jun 30, 2025 | 49.18% |
| Mar 31, 2025 | 51.49% |
| Dec 31, 2024 | 41.45% |
| Sep 30, 2024 | -28.70% |
| Jun 30, 2024 | -1,898.09% |
| Dec 31, 2022 | -28,244.66% |
| Sep 30, 2022 | -102,126.07% |
| Jun 30, 2022 | -38,773.09% |
| Mar 31, 2022 | -92,094.83% |
| Dec 31, 2021 | -13,794.92% |
| Sep 30, 2021 | -22,487.18% |
| Jun 30, 2021 | -71,813.31% |
| Mar 31, 2021 | -8,169.54% |
| Dec 31, 2020 | -10,921.20% |
| Sep 30, 2020 | -7,099.29% |
| Jun 30, 2020 | -54,251.71% |
API Access
CorMedix Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();